The Vertical Group

The Vertical Group is a venture capital firm specializing in early-stage investments in the life sciences sector, including medical devices, diagnostics, and biotechnology. Established in 1988, the firm has over 40 years of experience in the medical technology industry, with its principals having played key roles as founders, early-stage investors, major shareholders, and executives in numerous successful companies.

The firm's investment strategy focuses on innovative companies in the medical and biotech sectors, emphasizing both early and late-stage venture investments. The Vertical Group has been instrumental in founding, investing in, and managing several successful companies within the medical technology industry. Notable portfolio companies include American Medical Systems, AtheroMed, Cardiothoracic Systems, Inc., ForteBio, Integrated Vascular Systems, Masimo, Metabolix, Ventana Medical Systems, Wright Medical Group, and Xomed Surgical Products.

Headquartered in New York, The Vertical Group also maintains an office in San Mateo, California. The firm operates as an independent entity, succeeding the venture capital division of F. Eberstadt & Co. Its commitment to innovation drives its investment approach, aiming to support the development of successful medical technology ventures. However, the information provided by The Vertical Group should not be interpreted as investment advice or as an offer to buy or sell securities.